Provided by Tiger Fintech (Singapore) Pte. Ltd.

Cogent Biosciences, Inc.

6.80
+0.810013.52%
Post-market: 7.000.2000+2.94%16:52 EDT
Volume:2.72M
Turnover:18.38M
Market Cap:774.75M
PE:-3.34
High:6.99
Open:6.11
Low:6.11
Close:5.99
Loading ...
Dec 11, 2023

Major Issues Report

Form 8-K - Current report
Nov 07, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 02, 2023

Major Issues Report

Form 8-K - Current report
Aug 08, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 08, 2023

Major Issues Report

Form 8-K - Current report
Aug 08, 2023

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Jun 14, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Jun 08, 2023

Major Issues Report

Form 8-K - Current report
Jun 08, 2023

Major Issues Report

Form 8-K - Current report
Jun 06, 2023

Major Issues Report

Form 8-K - Current report
Jun 01, 2023

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
May 09, 2023

Major Issues Report

8-K - Current report
May 09, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Mar 14, 2023

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Mar 14, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 14, 2023

Major Issues Report

8-K - Current report
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals